Data on the use of psychotropic medications in specialist mental health services and interdisciplinary specialised treatment for substance use disorders (SUDs) are useful both as cross-sectional indicators and as time series data for monitoring trends. The figures can help form a basis for evaluating rational use of medications in hospitals. Purchasing data for anxiolytics, antidepressants, mood stabilisers and antipsychotics from the Hospital Pharmacies Drug Statistics for the period 2012-23 were used. The data are sourced from sales to specialist mental health clinics and for SUD treatment. Defined daily doses and the number of defined daily doses per 100 bed-days were used as units of measurement. Use of anxiolytics increased by 127 % from 2012 to 2023, while decreasing by 24 % for antidepressants. The use of mood stabilisers and lithium decreased by 26 % and 16 %, respectively. Total use of antipsychotics increased by 29 %, while rising by 79 % for depot injections. Significant changes in medication use were observed during the reference period. Further studies are needed to identify the causes and effects of the changed prescribing patterns.
A man in his sixties was diagnosed with diffuse large B-cell lymphoma localised in the base of his tongue. The patient was admitted to the emergency department with a fever, generalised muscle aches and lethargy 12 days atter receiving his first chemotherapy treatment with granulocyte-colony stimulating factor (G-CSF) supplementation. There were no focal signs of infection. The patient was started on empiric antibiotic treatment. After four days, C-reactive protein (CRP) had increased from 104 to 331, but the patient's condition was largely unchanged. A computer tomography (CT) scan showed aortitis, most likely caused by G-CSF. The patient was treated with prednisolone and rapidly improved. The diagnosis of G-CSF-induced aortitis should be considered in patients with fever after G-CSF treatment, particularly if adequate antibiotic treatment does not lead to improvement. Advanced imaging is often indicated. The most important measure is to discontinue G-CSF supplementation.
Data on phosphorus, color, cyanobacteria biovolume, total phytoplankton biovolume and cyanobacteria proportion of the total phytoplankton biovolume used for GAMM